ID   N18TG2 ChAT
AC   CVCL_E3K2
SY   N18-ChAT
RX   PubMed=10215905;
CC   Characteristics: Control cell line for the series of N18TG2 To/2 to To/9 cell lines (PubMed=10215905).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=RGD; 69313; Ache.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=10215905; DOI=10.1046/j.1460-9568.1999.00571.x;
RA   Bloc A., Bugnard E., Dunant Y.M., Falk-Vairant J., Israel M., Loctin F.,
RA   Roulet E.;
RT   "Acetylcholine synthesis and quantal release reconstituted by
RT   transfection of mediatophore and choline acetyltranferase cDNAs.";
RL   Eur. J. Neurosci. 11:1523-1534(1999).
//